Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02610777
What this trial is testing

An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute
Millennium Pharmaceuticals, Inc. 120
Not applicableUnknownNCT04662892
What this trial is testing

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

Who this might be right for
Febrile NeutropeniaNon-myeloid Malignancy
Coherus Oncology, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT07710534
What this trial is testing

Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

Who this might be right for
Relapsed / Refractory AMLHigh Risk Myelodysplastic SyndromeHigh Risk Myeloproliferative Neoplasms
Virginia Commonwealth University 40
Testing effectiveness (Phase 2)Study completedNCT01617226
What this trial is testing

Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS

Who this might be right for
Leukemia, Myeloid, Acute
University of Birmingham 260
Testing effectiveness (Phase 2)Study completedNCT00324220
What this trial is testing

A Phase I/II Study of MGCD0103 With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia

Who this might be right for
Myelodysplastic SyndromeAcute Myelogenous Leukemia
Mirati Therapeutics Inc. 66
Testing effectiveness (Phase 2)Looking for participantsNCT01515527
What this trial is testing

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 160
Testing effectiveness (Phase 2)Study completedNCT01869114
What this trial is testing

Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 57
Post-approval studies (Phase 4)Study completedNCT00686543
What this trial is testing

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Who this might be right for
Fungal InfectionAcute Myelogenous LeukemiaNeutropenia
Merck Sharp & Dohme LLC 75
Early research (Phase 1)Study completedNCT00828282
What this trial is testing

High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL

Who this might be right for
Chronic Lymphocytic Leukemia
John Haslip 3
Very early researchLooking for participantsNCT06802146
What this trial is testing

Early Intervention in High Risk CCUS

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceCytopenia
Lachelle D. Weeks, MD, PhD 108
Not applicableUnknownNCT00961285
What this trial is testing

Genotyping Analysis of Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult
University of Bologna 1,000
Large-scale testing (Phase 3)Study completedNCT00656448
What this trial is testing

Trial of Procrit vs. No Procrit in AML and High Risk MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT00790855
What this trial is testing

Bendamustine in Acute Leukemia and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00002638
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
University of Nebraska 30
Post-approval studies (Phase 4)Study completedNCT00408278
What this trial is testing

Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

Who this might be right for
Acute Promyelocytic Leukemia
PETHEMA Foundation 300
Testing effectiveness (Phase 2)Ended earlyNCT02477787
What this trial is testing

Randomized Study of Haploidentical Hct and Subsequent Donor nk Cell Infusion in High-risk AML and MDS

Who this might be right for
Acute Myelogenous Leukemia
Asan Medical Center 77
Testing effectiveness (Phase 2)Looking for participantsNCT03516617
What this trial is testing

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Mayo Clinic 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03913026
What this trial is testing

UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

Who this might be right for
High Risk Hematologic MalignancyCord Blood Transplant
Ciusss de L'Est de l'Île de Montréal 30
Large-scale testing (Phase 3)Ended earlyNCT01437787
What this trial is testing

Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis

Who this might be right for
Hematopoietic Neoplasm
Bristol-Myers Squibb 289
Early research (Phase 1)Ended earlyNCT03940352
What this trial is testing

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Novartis Pharmaceuticals 52
Next Page